product summary
Loading...
company name :
Bio-Rad
other brands :
Biogenesis, Serotec, AbD Serotec, Oxford Biotechnology
product type :
antibody
product name :
Rat anti Mouse CD45
catalog :
MCA1388
quantity :
0.25 mg
price :
372 USD
clonality :
monoclonal
host :
rat
conjugate :
nonconjugated
clone name :
IBL-3/16
reactivity :
mouse
application :
western blot, immunohistochemistry, immunocytochemistry, immunoprecipitation, flow cytometry, immunohistochemistry - paraffin section, immunohistochemistry - frozen section, immunohistochemistry - free floating section
more info or order :
citations: 27
Published Application/Species/Sample/Dilution | Reference |
---|---|
| |
| |
| |
| |
| |
| |
| |
| |
| |
| |
Sato E, Shick H, Ransohoff R, Hirose K. Repopulation of cochlear macrophages in murine hematopoietic progenitor cell chimeras: the role of CX3CR1. J Comp Neurol. 2008;506:930-42 pubmed
| |
Santos A, Calvente R, Tassi M, Carrasco M, Martín Oliva D, Marín Teva J, et al. Embryonic and postnatal development of microglial cells in the mouse retina. J Comp Neurol. 2008;506:224-39 pubmed
| |
He P, Zhong Z, Lindholm K, Berning L, Lee W, Lemere C, et al. Deletion of tumor necrosis factor death receptor inhibits amyloid beta generation and prevents learning and memory deficits in Alzheimer's mice. J Cell Biol. 2007;178:829-41 pubmed
| |
Yang Y, Varvel N, Lamb B, Herrup K. Ectopic cell cycle events link human Alzheimer's disease and amyloid precursor protein transgenic mouse models. J Neurosci. 2006;26:775-84 pubmed
|
image
image 1 :

Published customer image: . Rat anti Mouse CD45 antibody, clone IBL-3/16 used for the detection of mouse leukocytes by flow cytometry. Image caption: . Infiltration of GFP+ BM-cells in infarct and peri-infarct regions. (A-B) Dot plots of viable macrophages/granulocytes (CD11b+CD45high, top right quadrants) and microglia (CD11b+CD45dim, bottom right quadrants) in cortex from BM-chimeric unmanipulated mice and mice exposed to pMCAO. (C) Bar graph showing mean numbers of CD11b+CD45dim microglia and CD11b+CD45high macrophages/granulocytes in BM-chimeric mice 24 hours after pMCAO, subdivided based on expression of GFP (n = 5). Approximately 92% of of the CD45high population were GFP+ . (D) Estimation and comparison of mean numbers of CD11b+CD45dim microglia in non-chimeric (n = 10) versus BM-chimeric mice (n = 5) 24 hours after of pMCAO shows significantly fewer CD11b+CD45dim microglial cells in irradiated mice. (E) Overview, showing distribution of infiltrating GFP+ BM-derived cells into infarct (IF) and peri-infarct (P-IF) regions 24 hours after pMCAO. (E-G) By 24 hours, GFP+ single cells (F) and vessel-associated aggregates of GFP+ cells (arrows in G) were observed in infarct and peri-infarct regions. Some of the vessel-associated cells were round, leukocyte-like cells (arrows) while others were elongated cells lining the vasculature (arrow heads in G and in insert). (H) Bar graph showing mean numbers of single GFP+ cells and vessel-associated aggregates of GFP+ cells in ipsi- and contralateral cortex 24 hours after surgery (n = 10). (I-P) Immunohistochemical staining of CD45.1 (I, K), CD45.2 (J, L), IgG2a (M, O) and CD45 (N, P) in ischemic tissue in BM-chimeric (I, J, M, N) and non-chimeric mice (K, L, O, P) 24 hours after pMCAO. N.D, none detected. Scale bars: 200 μm (A), 10 μm (B, C). 50 μm (I-P) *P J Neuroinflammation. 2008 Oct 23;5:46.
product information
Entity Type :
Monoclonal Antibody
Entity Category :
Antibodies
ProductCode :
MCA1388
Description :
Rat anti Mouse CD45
Specificity :
CD45
TargetSpecies :
Mouse
Host :
Rat
Format :
Purified
Isotypes :
IgG1
Applications :
WB,P,IP,F,C,IF,RE
ApplicationTypes :
Western Blotting,Immunohistology - Paraffin,Immunoprecipitation,Flow Cytometry,Immunohistology - Frozen,Immunofluorescence,Immunohistology - Resin
Cross Reactivities :
Rat,Human,Chicken
Clone :
IBL-3/16
Quantity :
0.25 mg
Quantity Value :
0.25
Quantity Type :
mg
GO Accessions :
GO:0000187,GO:0001915,GO:0001916,GO:0001960,GO:0002925,GO:0051726,GO:0004725,GO:0005887,GO:0005925,GO:0006469,GO:0006470,GO:0007159,GO:0008201,GO:0009897,GO:0019901,GO:0030183,GO:0030890,GO:0031953,GO:0034113,GO:0042098,GO:0042100,GO:0043065,GO:0043395,GO:0043410,GO:0045059,GO:0045060,GO:0045121,GO:0045577,GO:0045588,GO:0046641,GO:0048304,GO:0050732,GO:0050852,GO:0050853,GO:0050855,GO:0050857,GO:0051209,GO:0051607
GOTerms :
activation of MAPK activity,negative regulation of T cell mediated cytotoxicity,positive regulation of T cell mediated cytotoxicity,negative regulation of cytokine-mediated signaling pathway,positive regulation of humoral immune response mediated by circulating immunoglobulin,regulation of cell cycle,protein tyrosine phosphatase activity,integral to plasma membrane,focal adhesion,negative regulation of protein kinase activity,protein dephosphorylation,leukocyte cell-cell adhesion,heparin binding,external side of plasma membrane,protein kinase binding,B cell differentiation,positive regulation of B cell proliferation,negative regulation of protein autophosphorylation,heterotypic cell-cell adhesion,T cell proliferation,B cell proliferation,positive regulation of apoptosis,heparan sulfate proteoglycan binding,positive regulation of MAPKKK cascade,positive thymic T cell selection,negative thymic T cell selection,membrane raft,regulation of B cell differentiation,positive regulation of gamma-delta T cell differentiation,positive regulation of alpha-beta T cell proliferation,positive regulation of isotype switching to IgG isotypes,negative regulation of peptidyl-tyrosine phosphorylation,T cell receptor signaling pathway,B cell receptor signaling pathway,regulation of B cell receptor signaling pathway,positive regulation of antigen receptor-mediated signaling pathway,release of sequestered calcium ion into cytosol,defense response to virus
Uniprot Accessions :
P06800
Gene :
Ptprc
GeneID URL :
http://www.ncbi.nlm.nih.gov/sites/entrez?Db=gene&Cmd=ShowDetailView&TermToSearch=19264
Published Synonyms :
LCA
Entity Formats :
Purified
UNSPSC :
41116161
Concentration :
IgG concentration 0.5 mg/ml
Product Form :
Purified IgG - liquid
PriceGBP :
266
PriceEUR :
372
PriceUSD :
372 USD
PriceCHF :
405
PriceSEK :
4055
PriceNOK :
4075
PriceDKK :
2774
more info or order :
company information

Bio-Rad
Endeavour House, Langford Business Park
Langford Lane, Kidlington
OXON, OX5 1GE
Langford Lane, Kidlington
OXON, OX5 1GE
antibody_sales_uk@bio-rad.com
https://www.bio-rad-antibodies.com1 800 265 7376 (North America)
44 (0)1865 852 700 (Rest of World)
44 (0)1865 852 700 (Rest of World)
headquarters: UK
Bio-Rad is one of the world's leading antibody manufacturers, offering over 12,000 antibodies and related reagents for a focused range of research areas such as immunology, cancer, veterinary research and cell biology through its antibody experts formerly known as AbD Serotec.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
The range includes apoptosis kits, autophagy reagents, CD markers, epitope tag antibodies, immunology antibodies, neuroscience antibodies, and veterinary reagents.
Bio-Rad has an ISO 9001 and ISO 13485 certified production facility in the United Kingdom as well as ISO 9001 certified facilities in Germany and the United States.
Our expertise extends to traditional and recombinant antibody generation and production services. Our custom generation service delivers antibodies in as little as 8 weeks with greater than 90% success. The in vitro technology enables selection of antibodies to challenging targets, long term consistent supply, and provision of the antibody sequence.
At Bio-Rad we are committed to your success when using our antibodies and we focus on providing the technology, products and all the supporting information you need to excel in your research.
related products
browse more products
questions and comments